Shareholders meeting

Krebs Biochemicals & Industries Limited CIN: L24110AP1991PLC103912 September 29, 2026 To, To, BSE Limited National Stock Exchange of India Ltd P J Towers, Dalal Street, Exchange Plaza, Bandra Kurla Complex, Fort, Mumbai- 400001. Bandra(E), Mumbai- 400051. Scrip Code : 524518 Scrip Code : KREBSBIO Dear Sir/Madam, Sub: Outcome / Proceedings of 34th Annual General Meeting of the Company Pursuant to Regulation 30 of the SEBI ( Listing Obligations and Disclosure Requirements ) Regulation, 2015, we are enclosing herewith the proceedings of the 34th Annual General Meeting of the Company held on Tuesday, September 29,, 2026 at 11:30 a.m. Kindly take the same on record. Thanking you, Yours Faithfully For Krebs Biochemicals & Industries Limited Rakesh R Kalbate Company Secretary & Compliance Officer ACS66666 Encl: A/a. Regd. Office : Kothapalli (V), Kasimkota (M), Anakapalli, Visakhapatnam, Andhra Pradesh-531 031 Tel : 040-66808040, Website: www.krebsbiochem.com, Email: com_sec@krebsbiochem.com Krebs Biochemicals & Industries Limited CIN: L24110AP1991PLC103912 PROCEEDINGS OF THE 34TH ANNUAL GENERAL MEETING OF THE MEMBERS OF THE COMPANY HELD ON TUESDAY, SEPTEMBER 29, 2026 1. The 34th Annual General Meeting of Krebs Biochemicals & Industries Limited was held through Video Conferencing / Other Audio Visual Means (VC/OAVM) on Tuesday, 29th September, 2026 at 11.30 a.m. 2. All the Directors including Chairman of the Audit and Nomination & Remuneration Committee of the Board, Chief Financial Officer and the Company Secretary were present at the Meeting through video conference. 3. The representatives of the Statutory Auditors, Secretarial Auditors and Scrutinizer were also present at the meeting through video conference. 4. Dr. R T Ravi, Chairman of the Board presided over the meeting. He informed that the quorum for the meeting is present in the meeting through VC. 5. At the request of the Chairman, the Company Secretary informed to the members that all the Statutory Registers and other documents relating to the Agendas of the meeting are available on the website of the Company for inspection by the members. 6. The Company Secretary informed that pursuant to the provisions of Section 108 of the Companies Act, 2013 read with the Companies (Management & Administration) Rules, 2014 as amended and Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, the Company has provided electronic voting facility to the Members entitled to cast their vote at the Annual General Meeting. The e-voting process was carried out by the Company between Friday, 25th September, 2026 to Monday, 28th September, 2026. 7. The notice convening the 34th Annual General Meeting was taken as read. 8. Thereafter, Dr. R T Ravi, Chairman, delivered his speech. 9. At the request of the Chairman, the Company Secretary informed to the members that the following items on the agenda as stated in the notice of this 34th Annual General Meeting requires the approval of the members. Regd. Office : Kothapalli (V), Kasimkota (M), Anakapalli, Visakhapatnam, Andhra Pradesh-531 031 Tel : 040-66808040, Website: www.krebsbiochem.com, Email: com_sec@krebsbiochem.com Krebs Biochemicals & Industries Limited CIN: L24110AP1991PLC103912 Ordinary Business: 1. To receive, consider, approve and adopt the Audited Balance Sheet, the Statement of Profit & Loss and Cash Flow Statement for the financial year ended 31st March 2026 together with the Notes attached thereto along with the Reports of Auditors and Directors thereon. 2. To appoint a director in place of Dr. R T Ravi (DIN- 00272977), who retires by rotation and being eligible, offers himself for re-appointment. 3. To appoint a director in place of Mr. Manish Kumar Jain ( DIN- 06477976), who retires by rotation and being eligible, offers himself for re-appointment. Special Business: 4. Approval for Related Party Transactions with Ipca Laboratories Limited. 5. To ratify the remuneration payable to the Cost Auditors. 10. The Company Secretary then requested the members to ask their questions, if any. 11. Thereafter, the Managing Director responded to the queries/questions raised by the Members. 12. The Chairman informed that Ms. Kritika Sharma, Practicing Company Secretary who was appointed as the Scrutinizer to scrutinize the remote e-voting process and that she is present at the meeting through video conference. 13. He also informed that the results of the voting will be declared after the report of the scrutinizer is received and shall be posted on the website of the Company and shall be displayed on the notice board of the Company at its registered office. 14. Thereafter, the he informed that the e voting module is available for voting to the members attending the Meeting and who have not cast their votes earlier for the next 15 minutes and thereafter, this Annual General Meeting shall deemed to be concluded with a vote of thanks. And the Meeting was concluded at 12:15 p.m. For Krebs Biochemicals & Industries Limited Rakesh R Kalbate Company Secretary & Compliance Officer ACS 66666 Regd. Office : Kothapalli (V), Kasimkota (M), Anakapalli, Visakhapatnam, Andhra Pradesh-531 031 Tel : 040-66808040, Website: www.krebsbiochem.com, Email: com_sec@krebsbiochem.com